iRhythm announces partnership with Lucem Health

iRhythm (IRTC) Technologies announced a strategic partnership with Lucem Health to accelerate early identification of undiagnosed arrhythmias in patient populations with an elevated risk for arrhythmias. “Healthcare is entering an era where the goal is no longer just to detect disease, but to predict it,” said Quentin Blackford, iRhythm President and CEO. “Together with Lucem Health, iRhythm is helping lead a new way forward in care, with the goal of reaching patients before symptoms surface and before complications arise. This is a bold step toward predictive, preventive, and precise care powered by AI, informed by data, and designed for scale. We believe more than 27 million people in the U.S. alone could benefit from proactive cardiac monitoring1 – and this is just the beginning.”